Kangmei Pharma | 600518 - Umsatzerlöse

Aktienkurs
1.71
Täglich Wechseln
-0.02 -1.16%
Monatlich
-3.39%
Jährlich
-14.07%
Q2 Prognose
1.69




Der Umsatz Veränderung Datum
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Dianthus Therapeutics USD 284K 112K 2025-12
Genomma Lab Internacional MXN 4.17B 150M 2026-03
Hypermarcas BRL 2.02B 217.07M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
IQVIA Holdings USD 4.36B 260M 2025-12
Jiangsu Hengrui CNY 8.14B 300M 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Moderna USD 678M 342M 2025-12
Organon & Co USD 1.46B 50M 2026-03
Revvity USD 772.06M 73.06M 2025-12
Sh Fosun Pharma CNY 10.07B 260M 2026-12
Tectonic Therapeutic USD 0 0 2024-12
Viatris USD 3.7B 60M 2025-12
Wuxi Apptec CNY 12.6B 160M 2026-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 162.37M 2026-03